The ability of UWWTP to remove NSAIDs: Impact on water quality in the Odra River Czech Republic concerning incoming European legislation
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989100%3A27350%2F24%3A10255654" target="_blank" >RIV/61989100:27350/24:10255654 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/61989100:27360/24:10255654
Výsledek na webu
<a href="https://www.sciencedirect.com/science/article/pii/S2772416624000780" target="_blank" >https://www.sciencedirect.com/science/article/pii/S2772416624000780</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.hazadv.2024.100477" target="_blank" >10.1016/j.hazadv.2024.100477</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
The ability of UWWTP to remove NSAIDs: Impact on water quality in the Odra River Czech Republic concerning incoming European legislation
Popis výsledku v původním jazyce
Increased consumption of pharmaceuticals has resulted in their detection in wastewater. If wastewater treatment plants (WWTPs) fail to eliminate these substances adequately, they can seep into the environment, posing potential risks. As non-steroidal anti-inflammatory drugs (NSAIDs) belong to the pharmaceuticals most frequently examined in wastewater, this study aimed to monitor wastewater from the municipal wastewater treatment plant in Ostrava (UWWTP) over the course of a year, specifically assessing how the presence of these substances in discharged wastewater could contaminate the Odra River. To further understand the impact of NSAIDs, we evaluated the effectiveness of UWWTP technology in removing the following selected drugs: diclofenac (DCF), ibuprofen (IBU), naproxen (NAP) and ketoprofen (KET) - as well as their main metabolites: 4'-hydroxydiclofenac (hydroxyDCF), carboxyibuprofen (carboxyIBU), desmethylnaproxen (desmethylNAP), and ketoprofen glucuronide (glucuronideKET).Wastewater samples were collected at both the inflow and outflow of the urban wastewater treatment plant (UWWTP) Ostrava from October 2022 to September 2023. The analysis was performed using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The concentrations of the monitored substances at the UWWTP inflow varied significantly, ranging from 79 ng/L to 112,125 ng/L, with the highest levels detected for ibuprofen (IBU), diclofenac (DCF), and their metabolites. The UWWTP demonstrated impressive treatment efficiency for IBU, exceeding 98%, while for DCF, it ranged between 56% and 87%. Building on these findings, a monitoring campaign was initiated along the Odra River to evaluate the concentrations of IBU and DCF - substances that had not been measured before. Water samples were taken from various locations along the Odra River from October to November 2023 and analyzed using the same methodology as the wastewater samples. The results indicate that, in line with the proposed environmental quality standards (EQS), IBU and DCF do not pose a significant contamination risk to the Odra River.
Název v anglickém jazyce
The ability of UWWTP to remove NSAIDs: Impact on water quality in the Odra River Czech Republic concerning incoming European legislation
Popis výsledku anglicky
Increased consumption of pharmaceuticals has resulted in their detection in wastewater. If wastewater treatment plants (WWTPs) fail to eliminate these substances adequately, they can seep into the environment, posing potential risks. As non-steroidal anti-inflammatory drugs (NSAIDs) belong to the pharmaceuticals most frequently examined in wastewater, this study aimed to monitor wastewater from the municipal wastewater treatment plant in Ostrava (UWWTP) over the course of a year, specifically assessing how the presence of these substances in discharged wastewater could contaminate the Odra River. To further understand the impact of NSAIDs, we evaluated the effectiveness of UWWTP technology in removing the following selected drugs: diclofenac (DCF), ibuprofen (IBU), naproxen (NAP) and ketoprofen (KET) - as well as their main metabolites: 4'-hydroxydiclofenac (hydroxyDCF), carboxyibuprofen (carboxyIBU), desmethylnaproxen (desmethylNAP), and ketoprofen glucuronide (glucuronideKET).Wastewater samples were collected at both the inflow and outflow of the urban wastewater treatment plant (UWWTP) Ostrava from October 2022 to September 2023. The analysis was performed using liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). The concentrations of the monitored substances at the UWWTP inflow varied significantly, ranging from 79 ng/L to 112,125 ng/L, with the highest levels detected for ibuprofen (IBU), diclofenac (DCF), and their metabolites. The UWWTP demonstrated impressive treatment efficiency for IBU, exceeding 98%, while for DCF, it ranged between 56% and 87%. Building on these findings, a monitoring campaign was initiated along the Odra River to evaluate the concentrations of IBU and DCF - substances that had not been measured before. Water samples were taken from various locations along the Odra River from October to November 2023 and analyzed using the same methodology as the wastewater samples. The results indicate that, in line with the proposed environmental quality standards (EQS), IBU and DCF do not pose a significant contamination risk to the Odra River.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
20700 - Environmental engineering
Návaznosti výsledku
Projekt
—
Návaznosti
S - Specificky vyzkum na vysokych skolach
Ostatní
Rok uplatnění
2024
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Hazardous Materials Advances
ISSN
2772-4166
e-ISSN
—
Svazek periodika
16
Číslo periodika v rámci svazku
listopad 2024
Stát vydavatele periodika
NL - Nizozemsko
Počet stran výsledku
11
Strana od-do
100477
Kód UT WoS článku
001328788600001
EID výsledku v databázi Scopus
—